NIBEC Co., Ltd. (KOSDAQ:138610)
South Korea · Delayed Price · Currency is KRW 25,600
-500 (-1.92%)
At close: Apr 9, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 292.67 billion as of April 10, 2026. Its market cap has increased by 85.81% in one year.
Market Cap
292.67B
Enterprise Value
279.34B
Revenue
32.72B
Ranking
n/a
PE Ratio
63.05
Stock Price
25,600.00
Market Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 292.67B, an increase of 681.84%. That is a compound annual growth rate of 14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 292.67B | -31.40% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kanaph Therapeutics | 460.59B |
| HansBiomed | 425.70B |
| Y-Biologics | 377.93B |
| S.Biomedics | 347.40B |
| Kangstem Biotech | 300.97B |
| TiumBio | 299.51B |
| curacle co.,ltd. | 296.76B |
| Bio Solution | 268.31B |